학술논문

Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
Document Type
Article
Source
Journal of Clinical Oncology; 1/20/2024, Vol. 42 Issue 3, p312-323, 14p
Subject
Language
ISSN
0732183X